BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 21.05.2025

FDA Announces Draft Guidance on Roflumilast

The FDA is releasing a new draft guidance for industry on roflumilast, which will provide product-specific recommendations for bioequivalence studies to support ANDA applications for the topical cream.

Source: Federal Register — Food and Drug AdministrationOpen original release →